Maintains Overweight
Friday, July 12, 2019
Key events next week – healthcare
Noteworthy events during the week of July 14 – 20 for healthcare investors.
SUNDAY (7/14): Alzheimer’s Association International Conference, Los Angeles (5 days). ProMIS Neurosciences (OTCQB:ARFXF): Data on lead candidate PMN310. Cortexyme (NASDAQ:CRTX): Design rationale for Phase 2/3 study of COR388.
MONDAY (7/15): World Diabetes Congress, Rome (3 days). Oramed Pharmaceuticals (NASDAQ:ORMP): Two presentation on oral insulin.
Cytori Therapeutics (NASDAQ:CYTX): Webcast on new strategic direction.
Health Catalyst files for upsized IPO
Health Catalyst (HCAT) has filed a preliminary prospectus for an IPO of 6.9M common shares at $20 – 23 per share, valuing the offering at over $148M at the midpoint.
In June, it filed for a $100M offering.
MediciNova readies late-stage study of MN-166 in progressive MS
Subsequent to FDA feedback, MediciNova (NASDAQ:MNOV) has finalized the protocol for a Phase 3 clinical trial evaluating MN-166 (ibudilast) in patients with secondary progressive multiple sclerosis (MS) without relapses.
The primary endpoint will be the time to three-month confirmed disability progression as measured by a scale called EDSS, the same endpoint used for other drugs approved for progressive MS.
The agency indicated that one study may be sufficient to support a marketing application.
The size of the study and its projected start date are not provided.
Subscribe to:
Posts (Atom)